ZA964710B - Novel compounds, the preparation and use thereof. - Google Patents

Novel compounds, the preparation and use thereof.

Info

Publication number
ZA964710B
ZA964710B ZA9604710A ZA964710A ZA964710B ZA 964710 B ZA964710 B ZA 964710B ZA 9604710 A ZA9604710 A ZA 9604710A ZA 964710 A ZA964710 A ZA 964710A ZA 964710 B ZA964710 B ZA 964710B
Authority
ZA
South Africa
Prior art keywords
preparation
novel compounds
novel
compounds
Prior art date
Application number
ZA9604710A
Other languages
English (en)
Inventor
Andreas Haupt
Franz Emling
Cynthia A Romerdahl
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of ZA964710B publication Critical patent/ZA964710B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ZA9604710A 1995-06-07 1996-06-06 Novel compounds, the preparation and use thereof. ZA964710B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/472,453 US5831002A (en) 1992-05-20 1995-06-07 Antitumor peptides

Publications (1)

Publication Number Publication Date
ZA964710B true ZA964710B (en) 1997-12-08

Family

ID=23875567

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA9604710A ZA964710B (en) 1995-06-07 1996-06-06 Novel compounds, the preparation and use thereof.
ZA9604711A ZA964711B (en) 1995-06-07 1996-06-06 Novel compounds, the preparation and use thereof.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ZA9604711A ZA964711B (en) 1995-06-07 1996-06-06 Novel compounds, the preparation and use thereof.

Country Status (33)

Country Link
US (1) US5831002A (de)
EP (2) EP0832104B1 (de)
JP (2) JP4221062B2 (de)
KR (2) KR100437986B1 (de)
CN (2) CN1182153C (de)
AR (2) AR003427A1 (de)
AT (2) ATE224910T1 (de)
AU (2) AU725164B2 (de)
BG (2) BG102125A (de)
BR (2) BR9609424A (de)
CA (2) CA2219818C (de)
CO (2) CO4700527A1 (de)
CZ (2) CZ293682B6 (de)
DE (2) DE69623992T2 (de)
DK (2) DK0832104T3 (de)
ES (2) ES2188759T3 (de)
HR (2) HRP960277A2 (de)
HU (2) HU228071B1 (de)
IL (2) IL122215A (de)
MX (2) MX9709147A (de)
MY (2) MY119042A (de)
NO (2) NO318384B1 (de)
NZ (2) NZ310444A (de)
PL (2) PL185763B1 (de)
PT (2) PT871656E (de)
RO (2) RO119783B1 (de)
SI (2) SI0832104T1 (de)
SK (1) SK282466B6 (de)
TR (2) TR199701544T1 (de)
TW (2) TW508357B (de)
UA (2) UA46775C2 (de)
WO (2) WO1996040752A1 (de)
ZA (2) ZA964710B (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5807984A (en) * 1995-11-09 1998-09-15 Basf Aktienegesellschaft Oligopeptides, the preparation and use thereof
TW474946B (en) * 1995-12-15 2002-02-01 Basf Ag Novel compounds, the preparation and use thereof
US20010009901A1 (en) * 1996-12-11 2001-07-26 Basf Aktiengesellschaft Germany Antineoplastic peptides
US5965537A (en) * 1997-03-10 1999-10-12 Basf Aktiengesellschaft Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the C-terminus
US6103698A (en) * 1997-03-13 2000-08-15 Basf Aktiengesellschaft Dolastatin-15 derivatives in combination with taxanes
US6143721A (en) * 1997-07-18 2000-11-07 Basf Aktiengesellschaft Dolastatin 15 derivatives
US6015790A (en) * 1997-10-06 2000-01-18 Basf Aktiengesellschaft Methods and compositions for treating rheumatoid arthritis
US5985837A (en) * 1998-07-08 1999-11-16 Basf Aktiengesellschaft Dolastatin 15 derivatives
EP1159273A1 (de) 1999-03-02 2001-12-05 Boehringer Ingelheim Pharmaceuticals Inc. Verbindungen, verwendbar als reversible inhibitoren von cathepsin s
US6420364B1 (en) 1999-09-13 2002-07-16 Boehringer Ingelheim Pharmaceuticals, Inc. Compound useful as reversible inhibitors of cysteine proteases
AU775373B2 (en) 1999-10-01 2004-07-29 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
US7018642B2 (en) 2001-04-27 2006-03-28 The Procter & Gamble Company Compounds, compositions, and methods for controlling biofilms
WO2003051835A2 (en) * 2001-12-18 2003-06-26 Proteologics, Inc. Methods and compositions for the inhibition of viral release
EP1531846A4 (de) * 2002-02-27 2006-04-19 Us Gov Health & Human Serv Konjugate aus ligand, linker und zytotoxischem agens sowie verwandte zusammensetzungen und verwendungsverfahren
EP1781310B1 (de) 2004-08-02 2015-10-14 Ramot at Tel Aviv University Ltd. Artikel von peptidnanostrukturen und herstellungsverfahren dafür
JP4954983B2 (ja) 2005-05-18 2012-06-20 ファーマサイエンス・インコーポレイテッド Ｂｉｒドメイン結合化合物
AU2006283677A1 (en) * 2005-08-19 2007-03-01 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Topical formulations of histone deacetylase inhibitors and methods of using the same
EP1973928A2 (de) * 2005-10-11 2008-10-01 Ramot at Tel-Aviv University Ltd. Selbstzusammengebaute fmoc-ff-hydrogele
CN101535300B (zh) 2006-05-16 2014-05-28 埃格拉医疗公司 Iap bir域结合化合物
JP5452223B2 (ja) * 2006-07-24 2014-03-26 テトラロジック ファーマシューティカルズ コーポレーション Ｉａｐ阻害剤
WO2008127560A1 (en) * 2007-04-12 2008-10-23 Scinopharm Taiwan Ltd. Process for making galantamine
UY32099A (es) 2008-09-11 2010-04-30 Enanta Pharm Inc Inhibidores macrocíclicos de serina proteasas de hepatitis c
US8283372B2 (en) 2009-07-02 2012-10-09 Tetralogic Pharmaceuticals Corp. 2-(1H-indol-3-ylmethyl)-pyrrolidine dimer as a SMAC mimetic
US9284350B2 (en) 2010-02-12 2016-03-15 Pharmascience Inc. IAP BIR domain binding compounds
CA2822556A1 (en) 2010-12-30 2012-07-05 Enanta Pharmaceuticals, Inc Macrocyclic hepatitis c serine protease inhibitors
EA201390988A1 (ru) 2010-12-30 2014-04-30 Энанта Фармасьютикалз, Инк. Фенантридиновые макроциклические ингибиторы сериновой протеазы вируса гепатита c
US10201584B1 (en) 2011-05-17 2019-02-12 Abbvie Inc. Compositions and methods for treating HCV
KR102356286B1 (ko) 2011-05-27 2022-02-08 암브룩스, 인코포레이티드 비-천연 아미노산 연결된 돌라스타틴 유도체를 함유하는 조성물, 이를 수반하는 방법, 및 용도
WO2015103490A1 (en) 2014-01-03 2015-07-09 Abbvie, Inc. Solid antiviral dosage forms
CN118119409A (zh) 2021-09-03 2024-05-31 东丽株式会社 癌的治疗和/或预防用药物组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816444A (en) * 1987-07-10 1989-03-28 Arizona Board Of Regents, Arizona State University Cell growth inhibitory substance
US4879278A (en) * 1989-05-16 1989-11-07 Arizona Board Of Regents Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 15
WO1993003054A1 (fr) * 1991-08-09 1993-02-18 Teikoku Hormone Mfg. Co., Ltd. Nouveau derive de tetrapeptide
CA2136339C (en) * 1992-05-20 2008-02-05 Andreas Haupt Derivatives of dolastatin
US5530097A (en) * 1994-08-01 1996-06-25 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory peptide amides
US5504191A (en) * 1994-08-01 1996-04-02 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory pentapeptide methyl esters

Also Published As

Publication number Publication date
CZ293682B6 (cs) 2004-07-14
DE69623472D1 (de) 2002-10-10
IL122216A0 (en) 1998-04-05
HUP9801910A3 (en) 1999-06-28
JPH11504652A (ja) 1999-04-27
PL185763B1 (pl) 2003-07-31
WO1996040752A1 (en) 1996-12-19
HU228073B1 (hu) 2012-09-28
JPH11504653A (ja) 1999-04-27
DK0871656T3 (da) 2003-01-27
PT871656E (pt) 2002-12-31
JP4221062B2 (ja) 2009-02-12
ATE223431T1 (de) 2002-09-15
US5831002A (en) 1998-11-03
NO318384B1 (no) 2005-03-14
CN1182154C (zh) 2004-12-29
WO1996040751A1 (en) 1996-12-19
ES2188759T3 (es) 2003-07-01
ES2186783T3 (es) 2003-05-16
PT832104E (pt) 2002-12-31
CN1187198A (zh) 1998-07-08
CN1187199A (zh) 1998-07-08
KR100437985B1 (ko) 2004-09-18
MX9709147A (es) 1998-03-31
MY119042A (en) 2005-03-31
SI0832104T1 (en) 2003-08-31
IL122215A0 (en) 1998-04-05
AU725170B2 (en) 2000-10-05
CN1182153C (zh) 2004-12-29
DE69623472T2 (de) 2003-08-21
NZ310444A (en) 1999-11-29
AU725164B2 (en) 2000-10-05
KR19990022583A (ko) 1999-03-25
SK282466B6 (sk) 2002-02-05
NO975710D0 (no) 1997-12-05
EP0832104B1 (de) 2002-09-04
NO975710L (no) 1998-02-02
CZ376397A3 (cs) 1998-06-17
UA46775C2 (uk) 2002-06-17
MX9709146A (es) 1998-03-31
BG102152A (en) 1998-09-30
DK0832104T3 (da) 2003-01-06
KR100437986B1 (ko) 2004-09-18
HRP960277A2 (en) 1997-10-31
ZA964711B (en) 1997-12-08
AR003427A1 (es) 1998-08-05
JP3957751B2 (ja) 2007-08-15
PL323726A1 (en) 1998-04-14
KR19990022582A (ko) 1999-03-25
TR199701544T1 (xx) 1998-03-21
CZ376597A3 (cs) 1998-06-17
NO975711D0 (no) 1997-12-05
CA2219819A1 (en) 1996-12-19
HUP9801910A2 (hu) 1999-01-28
HU228071B1 (hu) 2012-09-28
CA2219818C (en) 2008-05-20
CO4700526A1 (es) 1998-12-29
NO975711L (no) 1998-01-30
HUP9801817A2 (hu) 1998-11-30
HRP960257A2 (en) 1998-02-28
MY124487A (en) 2006-06-30
IL122215A (en) 2001-08-26
DE69623992T2 (de) 2003-05-22
PL185762B1 (pl) 2003-07-31
NZ310443A (en) 1999-10-28
EP0832104A1 (de) 1998-04-01
TR199701545T1 (xx) 1998-04-21
ATE224910T1 (de) 2002-10-15
NO317670B1 (no) 2004-11-29
BR9609423A (pt) 1999-06-29
EP0871656A1 (de) 1998-10-21
TW424096B (en) 2001-03-01
UA46776C2 (uk) 2002-06-17
DE69623992D1 (de) 2002-10-31
BG102125A (en) 1998-09-30
CA2219818A1 (en) 1996-12-19
AR003136A1 (es) 1998-07-08
SK165397A3 (en) 1998-10-07
EP0871656B1 (de) 2002-09-25
CZ293683B6 (cs) 2004-07-14
AU6124196A (en) 1996-12-30
HUP9801817A3 (en) 1999-06-28
RO119783B1 (ro) 2005-03-30
BR9609424A (pt) 2000-03-28
CO4700527A1 (es) 1998-12-29
RO118953B1 (ro) 2004-01-30
CA2219819C (en) 2008-05-20
IL122216A (en) 2002-02-10
PL323723A1 (en) 1998-04-14
SI0871656T1 (en) 2003-08-31
AU6124296A (en) 1996-12-30
TW508357B (en) 2002-11-01

Similar Documents

Publication Publication Date Title
ZA964710B (en) Novel compounds, the preparation and use thereof.
ZA972727B (en) A novel composition, its preparation and use.
EP0674898A3 (de) Shampoozusammensetzung.
MX213417B (es) Fenilpiridazinonas.
ZA966148B (en) Novel formulation.
ZA964468B (en) Triazolylmethyl-cyclopentanols.
AU6636598A (en) Novel 3,4-dialkoxyphenyl derivatives and the use thereof
ZA961955B (en) Indazolecarboxamides.
ZA965418B (en) Quick-fermented feed, its preparation and uses.
EP0664969A3 (de) Skischuh.
EP0599159A3 (de) a-L-Rhamnosidase zur Gewinnung von Rhamnose, ein Verfahren zur Herstellung und ihre Verwendung.
DE69610844D1 (en) Hydroformylierungsverfahren.
ZA959630B (en) Diaminocyclobutene-3, 4-diones.
ZA9610278B (en) Pyridylcarbamates, processes and intermediates for their preparation, and their use.
ZA963620B (en) (Het)aryloxy-, -thio- and -aminocrotonates, their preparation and their use.
ZA969402B (en) Novel oligopeptides, the preparation and use thereof.
PL326837A1 (en) 25-hydroxy-16-ene-26, 27-bishomocholecarctiferoles
ZA9810625B (en) Benzylidenepyrazolones, their preparation and use.
ZA966399B (en) Endothelin-receptor-antagonists.
EP0672364A3 (de) Skischuh.
ZA9610510B (en) Novel peptides, the preparation and use thereof.
ZA966750B (en) Halogenobenzimidazoles.
GR3034943T3 (en) Medrogestrone.
EP0671133A3 (de) Skischuh.
EP0657435A3 (de) 1,2-Dihydro-2-oxo-pyridine.